These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9203629)

  • 1. Selective activation of rolipram-sensitive, cAMP-specific phosphodiesterase isoforms by phosphatidic acid.
    Némoz G; Sette C; Conti M
    Mol Pharmacol; 1997 Feb; 51(2):242-9. PubMed ID: 9203629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the rolipram-sensitive, cyclic AMP-specific phosphodiesterases: identification and differential expression of immunologically distinct forms in the rat brain.
    Iona S; Cuomo M; Bushnik T; Naro F; Sette C; Hess M; Shelton ER; Conti M
    Mol Pharmacol; 1998 Jan; 53(1):23-32. PubMed ID: 9443929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cAMP-specific phosphodiesterase PDE4D3 is regulated by phosphatidic acid binding. Consequences for cAMP signaling pathway and characterization of a phosphatidic acid binding site.
    Grange M; Sette C; Cuomo M; Conti M; Lagarde M; Prigent AF; Némoz G
    J Biol Chem; 2000 Oct; 275(43):33379-87. PubMed ID: 10938092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rolipram inhibition of phosphodiesterase-4 activation.
    DiSanto ME; Heaslip RJ
    Eur J Pharmacol; 1995 Jul; 290(2):169-72. PubMed ID: 8575533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenge of human Jurkat T-cells with the adenylate cyclase activator forskolin elicits major changes in cAMP phosphodiesterase (PDE) expression by up-regulating PDE3 and inducing PDE4D1 and PDE4D2 splice variants as well as down-regulating a novel PDE4A splice variant.
    Erdogan S; Houslay MD
    Biochem J; 1997 Jan; 321 ( Pt 1)(Pt 1):165-75. PubMed ID: 9003416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphodiesterase 4 in macrophages: relationship between cAMP accumulation, suppression of cAMP hydrolysis and inhibition of [3H]R-(-)-rolipram binding by selective inhibitors.
    Kelly JJ; Barnes PJ; Giembycz MA
    Biochem J; 1996 Sep; 318 ( Pt 2)(Pt 2):425-36. PubMed ID: 8809029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation and activation of a cAMP-specific phosphodiesterase by the cAMP-dependent protein kinase. Involvement of serine 54 in the enzyme activation.
    Sette C; Conti M
    J Biol Chem; 1996 Jul; 271(28):16526-34. PubMed ID: 8663227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexamethasone down-regulates cAMP-phosphodiesterase in human osteosarcoma cells.
    Ahlström M; Pekkinen M; Huttunen M; Lamberg-Allardt C
    Biochem Pharmacol; 2005 Jan; 69(2):267-75. PubMed ID: 15627479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Action of rolipram on specific PDE4 cAMP phosphodiesterase isoforms and on the phosphorylation of cAMP-response-element-binding protein (CREB) and p38 mitogen-activated protein (MAP) kinase in U937 monocytic cells.
    MacKenzie SJ; Houslay MD
    Biochem J; 2000 Apr; 347(Pt 2):571-8. PubMed ID: 10749688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of cAMP-specific phosphodiesterases type 4B and 4D (PDE4) splice variants by cAMP signaling in primary cortical neurons.
    D'Sa C; Tolbert LM; Conti M; Duman RS
    J Neurochem; 2002 May; 81(4):745-57. PubMed ID: 12065634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential regulation of human monocyte-derived TNF alpha and IL-1 beta by type IV cAMP-phosphodiesterase (cAMP-PDE) inhibitors.
    Verghese MW; McConnell RT; Strickland AB; Gooding RC; Stimpson SA; Yarnall DP; Taylor JD; Furdon PJ
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1313-20. PubMed ID: 7891349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short term feedback regulation of cAMP in FRTL-5 thyroid cells. Role of PDE4D3 phosphodiesterase activation.
    Oki N; Takahashi SI; Hidaka H; Conti M
    J Biol Chem; 2000 Apr; 275(15):10831-7. PubMed ID: 10753877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular cloning and transient expression in COS7 cells of a novel human PDE4B cAMP-specific phosphodiesterase, HSPDE4B3.
    Huston E; Lumb S; Russell A; Catterall C; Ross AH; Steele MR; Bolger GB; Perry MJ; Owens RJ; Houslay MD
    Biochem J; 1997 Dec; 328 ( Pt 2)(Pt 2):549-58. PubMed ID: 9371714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipid regulation of a cyclic AMP-specific phosphodiesterase (PDE4) from U937 cells.
    DiSanto ME; Glaser KB; Heaslip RJ
    Cell Signal; 1995 Nov; 7(8):827-35. PubMed ID: 8593251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro differentiation of human monocytes to macrophages: change of PDE profile and its relationship to suppression of tumour necrosis factor-alpha release by PDE inhibitors.
    Gantner F; Kupferschmidt R; Schudt C; Wendel A; Hatzelmann A
    Br J Pharmacol; 1997 May; 121(2):221-31. PubMed ID: 9154331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of mRNA encoding cAMP-specific phosphodiesterase isoforms in rat parotid glands.
    Imai A; Nashida T; Shimomura H
    Biochem Mol Biol Int; 1996 Dec; 40(6):1175-81. PubMed ID: 8988329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacodynamic action of the cyclic AMP phosphodiesterase inhibitor rolipram on prolactin producing rat pituitary adenoma (GH4C1) cells.
    Gordeladze JO
    Biosci Rep; 1990 Aug; 10(4):375-88. PubMed ID: 2174276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of a cyclic nucleotide phosphodiesterase 4 (PDE4) from rat thymocytes by phosphatidic acid.
    Savany A; Abriat C; Némoz G; Lagarde M; Prigent AF
    Cell Signal; 1996 Nov; 8(7):511-6. PubMed ID: 9023016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oocyte maturation involves compartmentalization and opposing changes of cAMP levels in follicular somatic and germ cells: studies using selective phosphodiesterase inhibitors.
    Tsafriri A; Chun SY; Zhang R; Hsueh AJ; Conti M
    Dev Biol; 1996 Sep; 178(2):393-402. PubMed ID: 8812137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of type-selective phosphodiesterase inhibitors on glucose-induced insulin secretion and islet phosphodiesterase activity.
    Shafiee-Nick R; Pyne NJ; Furman BL
    Br J Pharmacol; 1995 Aug; 115(8):1486-92. PubMed ID: 8564209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.